Zane Kraft

1.2k total citations
21 papers, 909 citations indexed

About

Zane Kraft is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Zane Kraft has authored 21 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 8 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Zane Kraft's work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (8 papers) and Immune Cell Function and Interaction (7 papers). Zane Kraft is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (8 papers) and Immune Cell Function and Interaction (7 papers). Zane Kraft collaborates with scholars based in United States, Greece and Germany. Zane Kraft's co-authors include Leonidas Stamatatos, Susan W. Barnett, Indresh K. Srivastava, D. Noah Sather, Roland K. Strong, Hengyu Xu, Nina Derby, Irina Zharkikh, Brian Burke and Margaret A. Holmes and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Cancer Research.

In The Last Decade

Zane Kraft

21 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zane Kraft United States	17	687	423	289	271	236	21	909
Catherine M. Finnegan United States	11	599 0.9×	354 0.8×	470 1.6×	239 0.9×	144 0.6×	12	1.0k
Karen L. Saye-Francisco United States	9	476 0.7×	266 0.6×	273 0.9×	167 0.6×	273 1.2×	10	670
Ariel Halper-Stromberg United States	8	889 1.3×	626 1.5×	249 0.9×	360 1.3×	338 1.4×	8	1.1k
P L Nara United States	12	688 1.0×	479 1.1×	206 0.7×	321 1.2×	134 0.6×	15	898
Deepika Bhullar United States	5	252 0.4×	310 0.7×	213 0.7×	115 0.4×	119 0.5×	5	549
Bianca Schulte Germany	14	306 0.4×	181 0.4×	211 0.7×	412 1.5×	39 0.2×	25	792
Kathy Revesz United States	11	774 1.1×	444 1.0×	199 0.7×	308 1.1×	296 1.3×	16	849
Zhihai Si United States	17	1.1k 1.6×	558 1.3×	553 1.9×	528 1.9×	143 0.6×	19	1.4k
Gail Folena-Wasserman United States	8	375 0.5×	303 0.7×	257 0.9×	233 0.9×	126 0.5×	10	718
Béatrice Labrosse France	13	464 0.7×	250 0.6×	186 0.6×	397 1.5×	39 0.2×	18	856

Countries citing papers authored by Zane Kraft

Since Specialization

Citations

This map shows the geographic impact of Zane Kraft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zane Kraft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zane Kraft more than expected).

Fields of papers citing papers by Zane Kraft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zane Kraft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zane Kraft. The network helps show where Zane Kraft may publish in the future.

Co-authorship network of co-authors of Zane Kraft

This figure shows the co-authorship network connecting the top 25 collaborators of Zane Kraft. A scholar is included among the top collaborators of Zane Kraft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zane Kraft. Zane Kraft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Killebrew, Justin R, Shannon Okada, Lynn M. Amon, et al.. (2024). Abstract 4062: A novel method for generating regulated cytokine therapeutics: Safety and activity of a conditionally active cLAG3-IL2 capable of delivering IL2 to LAG3+ cells while remaining inert on LAG3- cells. Cancer Research. 84(6_Supplement). 4062–4062. 1 indexed citations

Freeman, Jeremy A., Jacques Friborg, Zane Kraft, et al.. (2014). Pegylated interferons Lambda‐1a and alfa‐2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells. Journal of Viral Hepatitis. 21(6). e1–9. 12 indexed citations

Lovelace, Erica S., Shokrollah Elahi, Nicholas J. Maurice, et al.. (2012). Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation. PLoS ONE. 7(7). e41832–e41832. 36 indexed citations

Sather, D. Noah, Sara Carbonetti, Zane Kraft, et al.. (2012). Broadly Neutralizing Antibodies Developed by an HIV-Positive Elite Neutralizer Exact a Replication Fitness Cost on the Contemporaneous Virus. Journal of Virology. 86(23). 12676–12685. 34 indexed citations

Klein, Florian, Christian Gaebler, Hugo Mouquet, et al.. (2012). Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein. The Journal of Experimental Medicine. 209(8). 1469–1479. 112 indexed citations

Lovelace, Erica S., Shokrollah Elahi, Nicholas J. Maurice, et al.. (2012). Correction: Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation. PLoS ONE. 7(10). 8 indexed citations

Sellhorn, George, Zane Kraft, Zachary Caldwell, et al.. (2011). Engineering, Expression, Purification, and Characterization of Stable Clade A/B Recombinant Soluble Heterotrimeric gp140 Proteins. Journal of Virology. 86(1). 128–142. 26 indexed citations

Malherbe, Delphine C., Nicole A. Doria‐Rose, Lynda Misher, et al.. (2011). Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies. Journal of Virology. 85(11). 5262–5274. 68 indexed citations

Friend, Della, Hengyu Xu, Zachary Caldwell, et al.. (2011). Binding Interactions between Soluble HIV Envelope Glycoproteins and Quaternary-Structure-Specific Monoclonal Antibodies PG9 and PG16. Journal of Virology. 85(14). 7095–7107. 34 indexed citations

10.

Robinson, James E., Debra Elliott, David C. Montefiori, et al.. (2010). Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIV _SF162P4. Journal of Virology. 84(7). 3443–3453. 37 indexed citations

11.

Correia, Bruno E., Margaret A. Holmes, Hengyu Xu, et al.. (2010). Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope. Structure. 18(9). 1116–1126. 161 indexed citations

12.

Kraft, Zane, Katharine Strouss, William F. Sutton, et al.. (2008). Characterization of Neutralizing Antibody Responses Elicited by Clade A Envelope Immunogens Derived from Early Transmitted Viruses. Journal of Virology. 82(12). 5912–5921. 19 indexed citations

13.

Polacino, Patricia, Kay Larsen, Lindsey Galmin, et al.. (2008). Differential pathogenicity of SHIV_{SF162 P4} infection in pig‐tailed and rhesus macaques. Journal of Medical Primatology. 37(s2). 13–23. 27 indexed citations

14.

Derby, Nina, Sean A. Gray, Elizabeth A. Wayner, et al.. (2007). Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens. Virology. 366(2). 433–445. 23 indexed citations

15.

Kraft, Zane, Nina Derby, Rachel Niec, et al.. (2007). Macaques Infected with a CCR5-Tropic Simian/Human Immunodeficiency Virus (SHIV) Develop Broadly Reactive Anti-HIV Neutralizing Antibodies. Journal of Virology. 81(12). 6402–6411. 40 indexed citations

16.

Xu, Rong, Indresh K. Srivastava, Catherine E. Greer, et al.. (2006). Characterization of Immune Responses Elicited in Macaques Immunized Sequentially with Chimeric VEE/SIN Alphavirus Replicon Particles Expressing SIVGag and/or HIVEnv and with Recombinant HIVgp140Env Protein. AIDS Research and Human Retroviruses. 22(10). 1022–1030. 28 indexed citations

17.

Xu, Rong, Indresh K. Srivastava, LaRene Kuller, et al.. (2006). Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. Virology. 349(2). 276–289. 30 indexed citations

18.

Burke, Brian, Nina Derby, Zane Kraft, et al.. (2006). Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies. Virology. 355(2). 138–151. 13 indexed citations

19.

Derby, Nina, Zane Kraft, Elaine Kan, et al.. (2006). Antibody Responses Elicited in Macaques Immunized with Human Immunodeficiency Virus Type 1 (HIV-1) SF162-Derived gp140 Envelope Immunogens: Comparison with Those Elicited during Homologous Simian/Human Immunodeficiency Virus SHIV_SF162P4and Heterologous HIV-1 Infection. Journal of Virology. 80(17). 8745–8762. 67 indexed citations

20.

Zharkikh, Irina, et al.. (2005). The V1, V2, and V3 Regions of the Human Immunodeficiency Virus Type 1 Envelope Differentially Affect the Viral Phenotype in an Isolate-Dependent Manner. Journal of Virology. 79(14). 9069–9080. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact